Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001084956 | SCV001058813 | likely benign | Peroxisome biogenesis disorder | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000676097 | SCV004161629 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | PEX6: BS2 |
Mayo Clinic Laboratories, |
RCV000676097 | SCV000801837 | uncertain significance | not provided | 2017-04-24 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001276738 | SCV001463266 | likely benign | Zellweger spectrum disorders | 2019-10-28 | no assertion criteria provided | clinical testing |